Myriad Genetics Inc

NASDAQ: MYGN
$15.49
+$0.37 (+2.4%)
Closing Price on November 22, 2024

MYGN Articles

In a new research report, Cowen analysts focus on three life science stocks that they think could beat current consensus earnings estimates.
Thursday's top analyst upgrades and downgrades include Apple, ASML, Charles Schwab, GoPro, Kraft Foods, Netflix and Red Hat.
Tuesday's top analyst upgrades and downgrades include AcelRx Pharmaceuticals, AECOM, Electronic Arts, Hewlett-Packard, Myriad Genetics and Urban Outfitters.
Myriad Genetics shares traded down as much as 16% Wednesday morning after the company lowered its fiscal-year guidance.
Wednesday's top analyst upgrades, downgrades and initiations include Coupons.com, Dean Foods, Hilton, Isis Pharma, National Oilwell Varco and Stratasys.
A new report from Cowen makes the case that a blood test that detects evidence of cancer in the circulation could soon replace the older more traditional biopsy methods.
Monday's top analyst upgrades, downgrades and initiations include BioMarin Pharmaceutical, BP, Home Depot, Petrobras and Target.
A new research note from Cantor Fitzgerald profiles stocks with upcoming earnings reports and huge short interest. These four stocks could absolutely hammer short sellers.
Thinkstock24/7 Wall St. has tracked several hot stocks on the move in Tuesday’s after-hours trading session. Most of the news is on earnings, but not all. Some of these stocks may change directions...
These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on is Friday, February 7, 2014. They include AOL, Echelon, Fairway, LinkedIn and Lululemon.
These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Wednesday, February 5, 2014. They include Arch Coal, ADM, Citigroup, Myriad Genetics and Sirius.
These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Monday, December 30, 2013.
Jon OggStocks are at all-time highs now that a deal has been reached in Washington, D.C., and investors have to wonder which stocks are set to keep rising and which ones may have overstayed their...
U.S. equity markets opened lower this morning, kicking off a gradual decline that lasted all day. Profit-taking and a lower-than-expected reading on consumer sentiment in the U.S. get the blame. In...
Jon OggInvestors and traders are frequently looking for fresh research ideas that will generate higher income or more profits. 24/7 Wall St. reviews many analyst research calls to find great ideas in...